SIGENP

Società Italiana di Gastroenterologia Epatologia e Nutrizione Pediatrica

  • Accedi
  • Home
  • News
  • Società
    Channel Consiglio Direttivo Commissioni Aree Comitato portale Sezioni regionali Rete Territoriale Statuto Bilanci Verbali Ufficio stampa
  • Formazione
    Calendario eventi residenziali Congresso Nazionale EDUCO Webinar SIGENP FAD SIGENP Calendario eventi patrocinati Richiedi patrocinio Archivio congressi Archivio Eventi Registrazioni eventi
  • Studi in corso
  • Giornale SIGENP
  • Pubblicazioni SIGENP
    Case report Linee guida Consensus statement Pubblicazioni soci Covid-19
  • Area pazienti
    Associazioni pazienti Articoli di interesse per i pazienti
  • Rassegna Stampa
  • Membership
  • Contatti
  • Passa al contenuto principale

SIGENP - Società Italiana di Gastroenterologia Epatologia e Nutrizione Pediatrica

Nuove terapie mediche per l’obesita’

NEW HORIZON FOR TREATMENT IN…

Advances in medical therapies for obesity

Paolo Ciampalini

Unità Operativa Complessa di Endocrinologia e Diabetologia - Ospedale Bambino Gesù – Roma

Obesity is a medical condition characterized by an excessive accumulation of body fat that can lead to negative effects on health, with a consequent reduction in life expectancy. Correct diet, physical exercise, and psychological approach are the basis for the preventive and curative therapy of obesity; to facilitate the treatment, slimming drugs can be prescribed that act by reducing appetite or inhibiting the absorption of fat. In addition to the classic criteria for defining an obese patient, the guidelines also focus on medical therapy as a prevention of possible complications of obesity, and the spread of messages and images via social media (where obesity is often addressed only for aesthetic reasons and not health) leads today to an almost frantic search for medical therapies to address and resolve the problem. Pharmacological research is very active in this sector, and in this brief overview we will see the molecules currently available on the market and the future ones that are being developed and that could be marketed within a few years. The most effective drugs are GLP-1 receptor analogues, molecules that increase the levels and action of GLP-1 in our body. Discovered almost by chance, they have revolutionized the therapy for obesity, also considering the relatively few side effects compared to the many advantages not only towards weight but towards the functioning of many organs of our body.

Accedi per visualizzare l'articolo

HOME
PRIVACY POLICY
AREA RISERVATA

SIGENP

Segreteria Amministrativa
c/o BioMedia srl
via Libero Temolo 4
20126, Milano
sigenp@biomedia.net

Designed by Biomedia srl
© 2025 SIGENP
P. IVA IT 09056111009

Login

Recupera password